Time To Crack Down On Cosmetic Surgery, Says Top Doctor

By Admin
Share
A top NHS doctor has urged the government to ‘crack down on the cosmetic surgery industry, citing a complete lack of regulation in some fields...

 

A top NHS doctor has urged the government to ‘crack down’ on the cosmetic surgery industry, citing a complete lack of regulation in some fields.

READ THE APRIL EDITION OF HEALTHCARE GLOBAL HERE

Bruce Keogh, the Health Service's Medical Director, called for tougher controls over “highly misleading” advertising and voiced his concern at the example set by television reality shows, in a review published on Wednesday.

He also raised doubts over the competence of non-Britain based “fly in, fly out” surgeons in carrying out facelifts, breast implants and nose straightening procedures.

Read Related Articles On Healthcare Global

The report highlighted “the many TV makeover programmes where participants have procedures financed by providers. Of particular concern are TV reality drama shows in which its young stars glamorise cosmetic procedures,” it added. “It is not always made clear that these celebrities have contracts with particular providers.”

Keogh said that those putting their faith in the hands of private surgeons did not have “the safety net that those using the NHS have.”

Health Minister Dan Poulter backed the recommendations and said the government would respond in the summer. “While there are some responsible clinics which do take proper care of their patients, Sir Bruce Keogh's review makes clear that there is a significant risk of people falling into the hands of cowboy firms or individuals whose only aim is to make a quick profit,” he said. “These people simply don't care about the welfare of the people they are taking money from.”

The review was commissioned after breast implants made by the French company PIP were found to contain substandard industrial-grade silicone.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma